Bionano Genomics (BNGO) Current Leases (2021 - 2026)

Bionano Genomics has disclosed Current Leases across 6 years of filings, most recently posting $646000.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $646000.0, down 59.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $646000.0 (down 59.42% YoY), and the FY2025 annual result was $697000.0, up 168.08% from the prior year.
• Current Leases came in at $646000.0 for Q1 2026 at Bionano Genomics, down from $697000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.3 million in Q4 2022 to a low of $251000.0 in Q3 2025.
• The 5-year median for Current Leases is $1.7 million (2022), against an average of $1.4 million.
• Peak annual rise in Current Leases reached 666.67% in 2024, while the deepest fall reached 87.98% in 2024.
• Bionano Genomics' Current Leases stood at $2.3 million in 2022, then dropped by 4.29% to $2.2 million in 2023, then tumbled by 87.98% to $260000.0 in 2024, then jumped by 168.08% to $697000.0 in 2025, then fell by 7.32% to $646000.0 in 2026.
• The last three Current Leases figures came in at $646000.0 (Q1 2026), $697000.0 (Q4 2025), and $251000.0 (Q3 2025), per Business Quant data.